0000899243-21-024126.txt : 20210616
0000899243-21-024126.hdr.sgml : 20210616
20210616160520
ACCESSION NUMBER: 0000899243-21-024126
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210528
FILED AS OF DATE: 20210616
DATE AS OF CHANGE: 20210616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOWEN MAXINE
CENTRAL INDEX KEY: 0001280044
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37773
FILM NUMBER: 211021510
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Merus N.V.
CENTRAL INDEX KEY: 0001651311
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: YALELAAN 62
CITY: 3584 CM UTRECHT
STATE: P7
ZIP: 3584 CM
BUSINESS PHONE: 31 030 253 8800
MAIL ADDRESS:
STREET 1: YALELAAN 62
CITY: 3584 CM UTRECHT
STATE: P7
ZIP: 3584 CM
FORMER COMPANY:
FORMER CONFORMED NAME: Merus B.V.
DATE OF NAME CHANGE: 20150819
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2021-05-28
2021-06-02
0
0001651311
Merus N.V.
MRUS
0001280044
GOWEN MAXINE
C/O MERUS N.V.
YALELAAN 62
UTRETCHT
P7
3584 CM
NETHERLANDS
1
0
0
0
Share option (right to buy)
21.15
2021-05-28
4
A
0
12240
0.00
A
2031-05-28
Common Shares
12240
12240
D
Options vest as to 33% on May 28, 2022 and as to 1/24th monthly thereafter, subject to the non-executive director continuing in service as a non-executive director through each such vesting date.
Due to an administrative error, the vesting information shown on the Reporting Person's Form 4 filed on June 2, 2021 was incorrect; the vesting terms have been corrected in the "Explanation of Responses" above. The remainder of the information contained in the June 2, 2021 Form 4 was correct and has been re-reported in this amendment for administrative purposes only. This amended Form 4 is intended only to correct the vesting schedule as noted above; all other information remains identical to the June 2, 2021 filing.
/s/ Peter Silverman as attorney-in-fact
2021-06-16